Protein hydrolysate derived from blue-backed fish

a protein hydrolysate and blue-backed fish technology, applied in the field of functional protein hydrolysates, can solve the problems of loss of autonomy, real challenges in maintaining satisfactory living conditions, product or ingredient on the nutraceutical or pet food market,

Pending Publication Date: 2022-09-08
SPECIALITES PET FOOD +8
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect of this patented method in treating neurological disorders by reducing inflammatory responses caused by excessive levels of certain substances called hydroxyproline (H1) hormone.

Problems solved by technology

This patent describes a problem where elderly people face aging issues related to cognitive declination and dementia. There is currently lacking any effective solution available for young people who want to live up to their full potential. Existing options like dietary supplements and exercise programs only provide temporary benefits, and they cannot stop the progressive decline of cognitiveness. Therefore, there is a need for a new product containing valuable components derived from natural resources, specifically bluefish, to improve longevity and autonomy for older people.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Protein hydrolysate derived from blue-backed fish
  • Protein hydrolysate derived from blue-backed fish
  • Protein hydrolysate derived from blue-backed fish

Examples

Experimental program
Comparison scheme
Effect test

example 1

and Methods

[0259]1.1. Cell Cultures

[0260]BV2:

[0261]BV2 cells are derived from a neonatal murine microglial cell line immortalized by the raf / mycet system, provided by Dr. Watterson (NorthWestern University, USA). They were grown in complete medium containing RPMI-Glutamax with 2 mM glutamine (Invitrogen, Life Technologies, France) supplemented with 10% inactivated fetal calf serum and 1% penicillin (100 U / mL)-streptomycin (100 μg / mL; Sigma-Aldrich, France) under a humid atmosphere with 5% CO2 at 37° C. as described by De Smedt-Peyrusse et al. (8).

[0262]When the cells had reached 80% to 90% confluence, they were treated for 24 hours with:[0263]DHA at the concentration of 16μM (Sigma-Aldrich, France). This concentration of DHA has been validated in the laboratory as an effective dose to demonstrate an anti-inflammatory effect.[0264]the hydrolysate according to the invention providing 16μM of DHA.

[0265]The cells were then treated for 2 h, 6 h or 24 h with 1 μg / mL of LPS (lipopolys

example 2

Effect of the Hydrolysate

[0355]2.1. Effect of H1 Hydrolysate on Neuroinflammation of BV2 Microglial Cells

[0356]Microglial cells are the immunocompetent cells of the brain, responsible for the production of cytokines. Inflammatory stress was induced in these cells (BV2 cells) by liposaccharide (LPS) using the protocol described in Example 1.1. The H1 protein hydrolysate was then tested for its ability to decrease the expression of the pro-inflammatory cytokines IL-6 (interleukin 6), IL-1β (interleukin 1beta) and TNF-α (tumor necrosis factor alpha), in these cells, according to the protocol described in Example 1.4.5.

[0357]The results show that in the control condition, LPS induces inflammatory stress with high expression of IL-6, IL-1β and TNF-α. DHA, which has anti-inflammatory capabilities, reduces LPS-induced IL-6 and IL-1β expression. Surprisingly, treatment with H1 hydrolysate decreases LPS-induced IL-6 and IL-1 expression with a greater effect than DHA (FIGS. 1a and 1b). The H1 hy

example 3

ffect of the Hydrolysate

[0368]For these in vivo tests, the animals were reared, fed and divided into different groups according to the protocol described in Example 1.2.

[0369]3.1. Effect of H2 Hydrolysate on Anxiety-Like Behaviour

[0370]The stress response involves the hypothalamic-pituitary-adrenal axis (HPA axis). In the presence of stress, the brain secretes cortisol in humans and corticosterone in mice, stress hormones that influence the immune system and allow a return to homeostasis. Once this return to homeostasis has been achieved, cortisol acts by negative feedback on the brain to reduce its own secretion.

[0371]In people suffering from anxiety, which accounts for 10% of the elderly, this axis is disrupted, leading to damage to the brain, particularly the hippocampus.

[0372]The effects of protein hydrolysate supplementation according to the invention on anxiety-like behaviour were studied by means of the so-called open-field (OF) test. The protocol of this test is described in Ex

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

A protein hydrolysate obtained from at least one protein source from bluefish having (i) a degree of hydrolysis (DH) of at least 10%, (ii) at least 80% water-soluble protein with a molecular weight of less than 1000 Da, (iii) at least 0.3% phospholipids, and (iv) at least 0.5% DHA and EPA.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SPECIALITES PET FOOD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products